Compounds of general structural formula I are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith.
대표청구항▼
Compounds of general structural formula I are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith. Pharmaceutica Hungarica vol. 63, (1993), pp. 91-98 (Hungarian). pp. 1-10 (English Translation Provided). L. Petocz et al., The Main Ph
Compounds of general structural formula I are selective NPY Y5 receptor antagonists, useful in the treatment of obesity and the complications associated therewith. Pharmaceutica Hungarica vol. 63, (1993), pp. 91-98 (Hungarian). pp. 1-10 (English Translation Provided). L. Petocz et al., The Main Pharmacological Characteristics of Grandaxin (Tofizopam, Egyt-341), Hungarian Medical Journal, vol. 23, No. 4, (1975), pp. 134-138. Petocz Luijza, "The Pharmacological Effects of Tofizopam (Grandaxin).RTM.", Acta Pharmaceutica Hungarica, vol. 63, (1993), pp. 79-82 (Hungarian. pp. 1-4 (English Translation Provided). Study of efficacy and safety of Grandaxin tablets for unidentified complaints with digestive system disease. Asano Sadhiro, Orita Yuichi, Kuga Masafumi and Amamor Masanori. Journal of New Remedies & Clinics, 1993, vol. 42, No. 12, pp. 2551-2556. English translation provided. Clinical Evaluation of Tofisopam (Grandaxin) on Gastro-intestinal Various Unidentified Complaints. Aoyagi Toshio, Kubo Akiyoshi, Sano Masaaki, Kashiwazaki Kazuo, Kojima Toshiya, Nishizato Yoshinori, Koizumi Kazumasa, Yoshioka Masahiro and Miyake Shozo. Japanese Pharmacology & Therapeutics, 1992, vol. 20, No. 2, pp. 657-667. English translation provided. From actual practice of diagnosis and treatment. Clinical effect of tofisopam (Grandaxin) on unidentified complaints of digestive system. Kitano Atsuo, Okabe Hiroshi, Nakamura Shiro, Obata Akishige, Oshitani Nobuhide, Hioki Masato, Matsumoto Takayuki, Okawa Kiyotaka and Kobaysashi Junzo. Journal of New Remedies & Clinics, 1988, vol. 37, No. 9, pp. 1735-1739. English translation provided. Effect of Tofisopam (Grandaxin) on irritable colon and cardiac neurosis. Hanajima H. Journal: Yakuri to chiryo. (Japanese pharmacology and therapeutics), 1987, vol. 15. No. 15, pp. 307-217. English translation provided.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (7)
Norman Mark Henry ; Hurt Clarence R. ; Chen Ning ; Fotsch Christopher H. ; Han Nianhe ; Jenkins Tracy J. ; Liu Longbin ; Moreno Ofir A., Compounds and methods which modulate feeding behavior and related diseases.
Gerald Christophe P. G. ; Weinshank Richard L. ; Walker Mary W. ; Branchek Theresa, DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5).
Gerald Christophe P. G. (Ridgewood NJ) Walker Mary W. (Elmwood Park NJ) Branchek Theresa (Teaneck NJ) Weinshank Richard L. (New York NY), DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof.
Johnson John D. ; Fu Shi-Liang ; Bluth Matthew J. ; Marble Robert A, Enhanced corrosion protection by use of friction reducers in conjuction with corrosion inhibitors.
Gerald Christophe P. G. ; Weinshank Richard L. ; Walker Mary W. ; Branchek Theresa, Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropep.
Hu Yinghe ; McCaleb Michael L. ; Bloomquist Brian T. ; Flores-Riveros Jaime R. ; Cornfield Linda J., Neuropeptide Y receptor Y5 and nucleic acid sequences.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.